- Home
- PLUR vs NMTC Comparison
PLUR vs NMTC Comparison
Compare PLUR & NMTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLUR
- NMTC
- Stock Information
- Founded
- PLUR 2001
- NMTC 2009
- Country
- PLUR Israel
- NMTC United States
- Employees
- PLUR N/A
- NMTC N/A
- Industry
- PLUR Biotechnology: Biological Products (No Diagnostic Substances)
- NMTC Medical/Dental Instruments
- Sector
- PLUR Health Care
- NMTC Health Care
- Exchange
- PLUR Nasdaq
- NMTC Nasdaq
- Market Cap
- PLUR 37.6M
- NMTC 45.0M
- IPO Year
- PLUR N/A
- NMTC N/A
- Fundamental
- Price
- PLUR $4.48
- NMTC $1.06
- Analyst Decision
- PLUR Strong Buy
- NMTC Strong Buy
- Analyst Count
- PLUR 1
- NMTC 2
- Target Price
- PLUR $12.00
- NMTC $2.23
- AVG Volume (30 Days)
- PLUR 9.3K
- NMTC 523.3K
- Earning Date
- PLUR 11-11-2025
- NMTC 08-14-2025
- Dividend Yield
- PLUR N/A
- NMTC N/A
- EPS Growth
- PLUR N/A
- NMTC N/A
- EPS
- PLUR N/A
- NMTC N/A
- Revenue
- PLUR $1,336,000.00
- NMTC $6,629,051.00
- Revenue This Year
- PLUR $246.11
- NMTC $151.98
- Revenue Next Year
- PLUR $169.62
- NMTC $31.96
- P/E Ratio
- PLUR N/A
- NMTC N/A
- Revenue Growth
- PLUR 309.82
- NMTC 69.00
- 52 Week Low
- PLUR $3.33
- NMTC $0.40
- 52 Week High
- PLUR $7.13
- NMTC $1.39
- Technical
- Relative Strength Index (RSI)
- PLUR 46.99
- NMTC 70.88
- Support Level
- PLUR $4.08
- NMTC $0.87
- Resistance Level
- PLUR $4.50
- NMTC $1.15
- Average True Range (ATR)
- PLUR 0.22
- NMTC 0.08
- MACD
- PLUR -0.02
- NMTC 0.01
- Stochastic Oscillator
- PLUR 65.05
- NMTC 67.23
About PLUR Pluri Inc.
Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.
About NMTC NeuroOne Medical Technologies Corporation
NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.